Home » Tenders » Americas » USA » Fenway-Lateral Flow Assay Evaluations Tender, USA - 103943967

Fenway-Lateral Flow Assay Evaluations Tender, USA - 103943967

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Fenway-Lateral Flow Assay Evaluations. The project location is USA and the tender is closing on 16 Jul 2024. The tender notice number is 000HCKBG-2024-86298, while the TOT Ref Number is 103943967. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Fenway-Lateral Flow Assay Evaluations

Deadline : 16 Jul 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 103943967

Document Ref. No. : 000HCKBG-2024-86298

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

NOTICE OF INTENT TO ISSUE AN ORDER. This is not a request for competitive proposals/quotes. The Centers for Disease Control and Prevention (CDC) hereby announces its intent to issue a sole source order to Fenway Institute for ntegrase Inhibitor-based Antiretroviral Therapy or Long-acting Pre-Exposure Prophylaxis (PrEP).

The NAICS code for this acquisition is 541715.

A determination by the Government not to compete this proposed action will be based on responses to this notice and is solely in the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

All vendors must be registered in the System for Award Management (SAM) at www.sam.gov, prior to an award of a federal contract.

This action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit quotations.

This is not a request for competitive quotations; however, the Government will review any/all product, capabilities, and pricing information submitted prior to the closure of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Responsible sources that believe they possess the expertise and capabilities identified above are hereby afforded the opportunity to submit to the Contracting Officer by the due date of this notice, their written capabilities statement and pricing information in the format they choose, not to exceed 10 pages. Please forward, as applicable, any capabilities, product, pricing informatio...
Active Contract Opportunity Notice ID 000HCKBG-2024-86298 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 08, 2024 08:14 am EDT
Original Date Offers Due: Jul 16, 2024 02:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Jul 31, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: AN22 - HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance: Atlanta, GA USA